Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
Alexandria University
Alejandría, EgiptoAlexandria University-ko ikertzaileekin lankidetzan egindako argitalpenak (8)
2024
-
Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trial
Intensive Care Medicine, Vol. 50, Núm. 2, pp. 247-257
-
Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: multispecialty, prospective cohort study in 25 countries
British Journal of Surgery, Vol. 111, Núm. 1
2023
-
Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study
Intensive Care Medicine, Vol. 49, Núm. 12, pp. 1441-1455
-
Mechanical Thrombectomy Global Access for Stroke (MT-GLASS): A Mission Thrombectomy (MT-2020 Plus) Study
Circulation, Vol. 147, Núm. 16, pp. 1208-1220
2017
-
Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trial
British Journal of Haematology, Vol. 179, Núm. 1, pp. 66-74
2016
-
Overall survival of patients with relapsed multiple myeloma treated with panobinostat or placebo plus bortezomib and dexamethasone (the PANORAMA 1 trial): a randomised, placebo-controlled, phase 3 trial
The Lancet Haematology, Vol. 3, Núm. 11, pp. e506-e515
-
Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by prior treatment
Blood, Vol. 127, Núm. 6, pp. 713-721